Comparable companies
- Dr. Duvillier CardiologieBrugge
- DR. LUC DE CLERCQ - REUMATOLOGIEAntwerpen
- Dr. Tim Wessels – Algemene Medische OncologieHolsbeek
- DOKTER ELISABETH PETITKapellen
- EVP ObstetricsHoeilaart
ImmunoJOIA
ActiveFrom the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
ImmunoJOIA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,301 and a net result of €16,301. Its solvency ranks better than 51% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 28-01-2025 Normal situation
- Legal form
- Private limited company
- Registered office
- Avenue des Dauphins 5, 1495 Villers-la-Ville
- Activity
- Specialist medical practice NACE 86220and 3 others
- Establishment unit
- 2.370.181.736 1495 Villers-la-Ville, since 28-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 30-03-2026
How it is doing
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €20,998
- Turnover
- ≈ €140,000
- estimated
- Profit
- €16,301
- Equity
- €18,301
- Total assets
- €28,620
2025 accounts 44 days early
Filed on 17-06-2026at the National Bank
Why 96raises riskFounded in 2025lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.77, cash €15,121Figures for financial year 2025 (filed 17-06-2026)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 66% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency
89
equity 63.9% of total assets
Liquidity
84
short-term debt 36.1% · cash 52.8%
Profitability
100
return on assets 57.0%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
02-2026: 0.3%
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value
10-2026: < 0.1%▼ -0.4 percentage points vs 09-2026lowest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity ample (current ratio 2.77, above the usual 1.5; short-term debt: 36.1% and cash: 52.8% of total assets), and 36.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 52% on solvency, 66% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
44 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Key points
- Caution: Among the weakest 17% on equitysector median €124,506 · 20,661 companies €18,301 View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 17-06-2026
Acts in the Belgian Official Gazette
- Incorporationact of 30-01-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about ImmunoJOIA
- What is the company number of ImmunoJOIA?
- 1019.279.958. In Belgium the VAT number is the company number with BE in front: BE 1019.279.958.
- Where is ImmunoJOIA based?
- The registered office is at Avenue des Dauphins 5, 1495 Villers-la-Ville.Company details
- What does ImmunoJOIA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of ImmunoJOIA?
- Private limited company (BV).
- When was ImmunoJOIA founded?
- On 28-01-2025.
- Is ImmunoJOIA still active?
- Yes, ImmunoJOIA is an active enterprise in the KBO register.
- What is the turnover of ImmunoJOIA?
- ≈ €140,000 in financial year 2025. Estimated from the gross margin of €20,998: probably between €95,000 and €230,000, based on 48 comparable companies, NACE 86. A rough estimate.Financials
- Is ImmunoJOIA profitable?
- In financial year 2025, ImmunoJOIA made a profit of €16,301.
- Where can I find the annual accounts of ImmunoJOIA?
- ImmunoJOIA filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank
Companies related to ImmunoJOIA
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.